Fallowfield, PA, United States of America

Brent Douty

This inventor holds 25 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in PI3K Inhibitors. Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brent Douty. Retrieved from https://idiyas.com/inventor/brent-douty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 7.1

ph-index = 9

Forward Citations = 259(Granted Patents)

Company Filing History:

Incyte Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

PI3K Inhibitors

Heterocyclylamines

Tricyclic Urea Compounds

Aminopyrazine Derivatives

Imidazo[2,1-f][1,2,4]triazines

Tertiary Alcohols

Pyrazolopyrimidine Derivatives

Crystalline Forms

Substituted Pyrrolo[2,3-c]pyridines

BET Protein Inhibitors

Phosphoinositide 3-Kinase

JAK2 V617F Inhibitors

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516065 - Tertiary alcohols as PI3K-γ inhibitors (2026-01-06),

2. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors (2025-09-23),

3. 12173006 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor (2024-12-24),

4. 12152033 - Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders (2024-11-26),

5. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors (2024-07-09),

6. 11926630 - Tertiary alcohols as PI3K-γ inhibitors (2024-03-12),

7. 11819505 - Heterocyclylamines as PI3K inhibitors (2023-11-21),

8. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors (2023-10-10),

9. 11661422 - Tricyclic urea compounds as JAK2 V617F inhibitors (2023-05-30),

10. 11433071 - Heterocyclylamines as PI3K inhibitors (2022-09-06),

11. 11225486 - Tertiary alcohols as PI3K-γ inhibitors (2022-01-18),

12. 11186580 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor (2021-11-30),

13. 11046658 - Aminopyrazine derivatives as PI3K-γ inhibitors (2021-06-29),

14. 10975088 - Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors (2021-04-13),

15. 10738057 - Tertiary alcohols as PI3K-γ inhibitors (2020-08-11),

Title: The Inventor Profile of Brent Douty

Introduction: Brent Douty, a talented inventor hailing from Fallowfield, PA (US), has made significant contributions to the field of innovation with his creative ideas and problem-solving skills.

Latest Patents: Brent Douty holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on sustainable energy solutions and smart home devices.

Career Highlights: Throughout his career, Brent Douty has been recognized for his groundbreaking inventions that have improved efficiency and sustainability in different sectors. His innovative mindset and dedication to finding solutions to complex problems have set him apart in the world of inventors.

Collaborations: Brent Douty has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have led to successful product launches and advancements in technology that have benefited society as a whole.

Conclusion: In conclusion, Brent Douty's passion for innovation and his commitment to making a positive impact through his inventions make him a standout figure in the world of inventors. His work continues to inspire others to push the boundaries of what is possible through creative thinking and ingenuity.

Profile summary based on public USPTO records.